Dr Anandi Martin is a microbiologist specialized in mycobacteria field research. She is currently the Operational Manager at the Pôle de Microbiologie, at the Université Catholique de Louvain (UCL), Brussels, Belgium. She completed her undergraduate studies at the University of Liège (ULg Belgium), then she worked 2 years in Bolivia (1996-1998) within the National Tuberculosis (TB) Programme as the scientific coordinator of project. She worked also 9 months in Siberia (1999) with “Médecins Sans Frontières” (MSF) where she built a TB culture laboratory in a prison. After her field experience, she joined the Institute of Tropical Medicine (ITM) in Antwerp, Belgium where she started a PhD focuses on the development of new method to detect drug resistance in TB. She completed her doctoral thesis in 2006 in collaboration with Ghent University (UGent, Belgium). 

She has more than 18 years of experience in the field of mycobacteriology. Her research interest focuses in different aspects of TB diagnostics, drug resistance, operational and basic research on TB including the study of non-tuberculous mycobacteria. She has been involved in several European Commission (EU) funded research projects (FP5 to FP7) for more than 10 years. She was part of the team that conducted the clinical trials in MDR-TB patients treated with the new diarylquinoline TMC207 (bedaquiline). Furthermore, she has a vast field experience in several countries in Latin-America, Africa and Asia.  Her contribution in TB field has been recently recognized by World Health Organization (WHO) in 2011 with the recommendation of her test as a diagnostic test for TB drug testing worldwide (non-commercial colorimetric methods).  She is one of the founders of an International Tuberculosis Research consortium called “EurolacTB” (European-Latin American-Caribbean-Tuberculosis) a network of more than 50 well known scientists working in Europe and in Latin America that join effort to fight against TB (http://eurolactb.strikingly.com/). She is a senior lecturer for the American Society of Microbiology (ASM) lab-Cap Programme, she has been involved in expert-group committee of WHO in TB and she is a member of the WHO STOP-TB partnership. Finally, she has published more than 100 papers in peer-reviewed journals, several book chapters and 1 book https://scholar.google.com/citationsview_op=list_works&hl=en&user=nhkXtaQAAAAJ ). Further, she has organized several top level international TB conference, and workshops. She co-supervised and trained a number of PhD, master students and young scientists.